In comparison with the classical hCG trigger, the GnRH-agonist-stimulated LH peak remarkably lowers the risk of inducing OHSS, but it is shorter and biologically weaker, resulting in insufficient support for the corpus luteum during the luteal phase [26]. Here, PLOD1 is linked to ovarian hyperstimulation syndrome.